Low within‐ and between‐day variability in exposure to new insulin glargine 300 U/ml

Abstract

Gla-300 provides predictable, evenly distributed 24-h coverage as a result of low fluctuation and high reproducibility in insulin exposure, and appears suitable for effective basal insulin use.